| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $539.49 | $10,789,812.78 | -0.9% | +18.5% | +9.1% | |
| Aug 4, 2021 | BIO Bio-Rad Laboratories, Inc. | Daskal Ilan53 | EVP, Chief Financial Officer | Sell | 2,300 | $751.84 | $1,729,240.85 | -54.1% | +2.2% | -29.3% | |
| Aug 4, 2021 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 1,000 | $1,500.00 | $1,500,000.00 | -13.7% | -3.0% | -11.1% | |
| Aug 4, 2021 | MEDP Medpace Holdings, Inc. | Keating Ashley M.67 | Director | Sell | 1,000 | $178.00 | $178,000.00 | -100% | +27.8% | -7.0% | |
| Aug 4, 2021 | BIO Bio-Rad Laboratories, Inc. | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 327 | $760.26 | $248,605.02 | -26.2% | +2.2% | -29.3% | |
| Aug 4, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 100,000 | $34.68 | $3,467,763.91 | -6.7% | -11.5% | -21.3% | |
| Aug 4, 2021 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 10,000 | $69.67 | $696,727.30 | -0.5% | -9.2% | -55.1% | |
| Aug 4, 2021 | XGN Exagen Inc. | Tullis James L L73 | Director | Sell | 8,200 | $11.71 | $95,989.37 | -0.2% | +4.3% | -26.9% | |
| Aug 3, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 4,020 | $70.35 | $282,807.00 | -0.8% | -7.5% | -57.8% | |
| Aug 3, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 2,702 | $117.27 | $316,863.54 | -6.2% | +6.6% | -61.3% | |
| Aug 3, 2021 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | Director | Sell | 5,000 | $1,489.82 | $7,449,119.84 | -1.7% | -3.5% | -9.1% | |
| Aug 3, 2021 | MYGN Myriad Genetics Inc | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 14,983 | $35.14 | $526,475.65 | -4.4% | -11.5% | -26.4% | |
| Aug 3, 2021 | MYGN Myriad Genetics Inc | Langer Dennis63 | Director | Sell | 30,000 | $34.75 | $1,042,500.00 | -25.1% | -11.5% | -26.4% | |
| Aug 3, 2021 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 1,250 | $1,486.18 | $1,857,725.00 | -91.0% | -3.5% | -9.1% | |
| Aug 3, 2021 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $535.59 | $10,711,859.50 | -0.6% | +18.3% | +9.7% | |
| Aug 2, 2021 | TWST Twist Bioscience Corp | Leproust Emily M.77 | President &CEO | Sell | 2,000 | $120.49 | $240,971.04 | -0.2% | +7.9% | -61.8% | |
| Aug 2, 2021 | VCYT Veracyte, Inc. | Eastham Karin65 | Director | Sell | 4,400 | $43.91 | $193,193.91 | -29.8% | +17.9% | -39.4% | |
| Aug 2, 2021 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 19,970 | $107.50 | $2,146,775.00 | -2.7% | -10.1% | -55.8% | |
| Aug 2, 2021 | TMO Thermo Fisher Scientific Inc. | Stevenson Mark59 | Executive Vice President &COO | Sell | 26,925 | $535.38 | $14,415,219.76 | -3.7% | +19.1% | +10.0% | |
| Aug 2, 2021 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 1,035 | $1,483.00 | $1,534,905.00 | -17.4% | -2.4% | -9.4% | |
| Aug 2, 2021 | MTD Mettler Toledo International Inc/ | Salice Thomas P65 | Director | Sell | 11,500 | $1,482.53 | $17,049,120.00 | -4.4% | -2.4% | -9.4% | |
| Aug 2, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 3,480 | $70.21 | $244,314.81 | -0.4% | -6.7% | -58.2% | |
| Jul 30, 2021 | TMO Thermo Fisher Scientific Inc. | Manzi Jim P52 | Director | Sell | 572 | $536.54 | $306,899.16 | -3.1% | +14.9% | +11.0% | |
| Jul 30, 2021 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 6,700 | $298.93 | $2,002,817.60 | -8.7% | +2.4% | -1.7% | |
| Jul 30, 2021 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 2,640 | $111.17 | $293,488.80 | -8.1% | -10.3% | -58.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.